Shedding the Light on Post-Vaccine Myocarditis and Pericarditis in COVID-19 and Non-COVID-19 Vaccine Recipients

Myocarditis and pericarditis have been linked recently to COVID-19 vaccines without exploring the underlying mechanisms, or compared to cardiac adverse events post-non-COVID-19 vaccines. We introduce an informatics approach to study post-vaccine adverse events on the systems biology level to aid the...

Full description

Bibliographic Details
Published in:	Vaccines
Main Authors:	Rima Hajjo, Dima A. Sabbah, Sanaa K. Bardaweel, Alexander Tropsha
Format:	Article
Language:	English
Published:	MDPI AG 2021-10-01
Subjects:	COVID-19 myocarditis pericarditis SARS-CoV-2 systems biology vaccine
Online Access:	https://www.mdpi.com/2076-393X/9/10/1186

Similar Items

Myocarditis and pericarditis after vaccination for COVID‐19
by: Blake Hudson, et al.
Published: (2021-08-01)

COVID-19 Vaccine-Induced Myocarditis and Pericarditis: Towards Identification of Risk Factors
by: Laura C. Zwiers, et al.
Published: (2023-07-01)

Correction: COVID-19 Vaccine-Induced Myocarditis and Pericarditis: Towards Identification of Risk Factors
by: Laura C. Zwiers, et al.
Published: (2024-01-01)

Myocarditis or Pericarditis Following the COVID-19 Vaccination in Adolescents: A Systematic Review
by: Minglong Li, et al.
Published: (2022-08-01)

Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand
by: Chayanit Mahasing, et al.
Published: (2023-03-01)

Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination: What Do We Know So Far?
by: Bibhuti B. Das, et al.
Published: (2021-07-01)

Myocarditis and pericarditis in patients with COVID-19
by: Jassim Zaheen Shah, et al.
Published: (2020-01-01)

COVID 19 Vaccine for Adolescents. Concern about Myocarditis and Pericarditis
by: Giuseppe Calcaterra, et al.
Published: (2021-09-01)

Disentangling a Thorny Issue: Myocarditis and Pericarditis Post COVID-19 and Following mRNA COVID-19 Vaccines
by: Concetta Rafaniello, et al.
Published: (2022-04-01)

Top 10 drugs most frequently associated with adverse events of myocarditis and pericarditis
by: Jaehyeong Cho, et al.
Published: (2025-08-01)

Risk of Myocarditis and Pericarditis among Young Adults following mRNA COVID-19 Vaccinations
by: Abdallah Alami, et al.
Published: (2022-05-01)

A Pharmacoepidemiological Study of Myocarditis and Pericarditis Following the First Dose of mRNA COVID-19 Vaccine in Europe
by: Joana Tome, et al.
Published: (2023-04-01)

The incidence and clinical characteristics of myocarditis and pericarditis following mRNA-based COVID-19 vaccination in Republic of Korea adolescents from July 2021 to September 2022
by: Ju-Young Sim, et al.
Published: (2023-04-01)

Risk of myocarditis and pericarditis following coronavirus disease 2019 messenger RNA Vaccination—A nationwide study
by: Wei-Ju Su, et al.
Published: (2023-06-01)

Causal relationship between COVID-19 and myocarditis or pericarditis risk: a bidirectional Mendelian randomization study
by: Guihong Liu, et al.
Published: (2023-12-01)

Myocarditis/pericarditis following vaccination with BNT162b2, CoronaVac, and ChAdOx1 among adolescent and adult in Malaysia
by: Norazida Ab Rahman, et al.
Published: (2023-08-01)

Clinical Course, Outcomes, and Risk Factors of Myocarditis and Pericarditis Following Administration of mRNA-1273 Vaccination: A Protocol for a Federated Real-World Evidence Vaccine Safety Study Using Data from Five European Data Sources
by: Laura C. Zwiers, et al.
Published: (2025-07-01)

Myocarditis and pericarditis in young patients following Campylobacter jejuni enterocolitis infection: a systematic review of case studies
by: Katharine Sanicola, et al.
Published: (2024-11-01)

A review of COVID-19 vaccination and the reported cardiac manifestations
by: Jamie Sin Ying Ho, et al.
Published: (2023-09-01)

COVID-19 mRNA Vaccine and Myocarditis
by: Balraj Singh, et al.
Published: (2021-06-01)

Myopericarditis in a Young Adult Secondary to COVID-19 Vaccination
by: Corbin G. Walters, et al.
Published: (2021-09-01)

Pericarditis due to an unusual microorganismin an immunocompromised patient
by: Flora Özkalaycı, et al.
Published: (2019-09-01)

Myocarditis and pericarditis in individuals exposed to the Ad26.COV2.S, BNT162b2 mRNA, or mRNA-1273 SARS-CoV-2 vaccines
by: Manan Pareek, et al.
Published: (2023-11-01)

Myocarditis and pericarditis following mRNA vaccination in autoimmune inflammatory rheumatic disease patients: A single‐center experience
by: Shreeya Patel, et al.
Published: (2022-06-01)

Analyzing the Systems Biology Effects of COVID-19 mRNA Vaccines to Assess Their Safety and Putative Side Effects
by: Rima Hajjo, et al.
Published: (2022-06-01)

Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries
by: Sophie H. Bots, et al.
Published: (2022-11-01)

A multiprovincial retrospective analysis of the incidence of myocarditis or pericarditis after mRNA vaccination compared to the incidence after SARS-CoV-2 infection
by: Zaeema Naveed, et al.
Published: (2024-03-01)

mRNA COVID-19 vaccine safety among children and adolescents: a Canadian National Vaccine Safety Network cohort studyResearch in context
by: Phyumar Soe, et al.
Published: (2024-12-01)

Sitagliptin: a potential drug for the treatment of COVID-19?
by: Bardaweel Sanaa K., et al.
Published: (2021-06-01)

A case of transient constrictive pericarditis following COVID-19 infection
by: Omar Fakhreddine, et al.
Published: (2023-01-01)

Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase
by: Milo Gatti, et al.
Published: (2021-01-01)

Benefit-risk assessment of Covid-19 vaccine, MRNA (MRNA-1273) for males age 18–64 years
by: Osman N. Yogurtcu, et al.
Published: (2023-08-01)

Uneventful COVID-19 Infection and Vaccination in a Cohort of Patients with Prior Myocarditis
by: Anna Baritussio, et al.
Published: (2023-11-01)

Life-threatening constrictive pericarditis accompanied by synthetic cannabinoid use: A case report and literature review
by: Mahsa Behnemoon, et al.
Published: (2024-07-01)

Immune checkpoint inhibitor-associated myocarditis and pericarditis: a pharmacovigilance study based on the FAERS database
by: Guojing Yao, et al.
Published: (2025-08-01)

COVID-19 pericarditis mimicking an acute myocardial infarction: a case report and review of literature
by: Binita Bhandari, et al.
Published: (2021-05-01)

Myopericarditis in a Male Adolescent Following the Second Shot of COVID-19 Pfizer m-RNA Vaccine: Typical Example and Analysis of 110 Single Case Reports
by: Alessandra Piras, et al.
Published: (2022-09-01)

Comparison of COVID-19 Vaccine-Associated Myocarditis and Viral Myocarditis Pathology
by: Kamron Reza Hamedi, et al.
Published: (2023-02-01)

Rare Heterogeneous Adverse Events Associated with mRNA-Based COVID-19 Vaccines: A Systematic Review
by: Rana I. Oueijan, et al.
Published: (2022-08-01)

Myocarditis following AstraZeneca (an adenovirus vector vaccine) COVID‐19 vaccination: A case report
by: Shakiba Hassanzadeh, et al.
Published: (2022-04-01)